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Abstract
Microcystin-LR (MC-LR) is affecting the water supply worldwide. Hence, a way to
eliminate this toxin is an essential target. In this study, successful cloning of the mlrA gene and
producing MlrA enzyme that can degrade the cyclic MC-LR to linearized MC-LR was done.
MlrA protein was expressed in Escherichia coli BL-21 (E. coli). Also, enhancing the MlrA yield
by adding nickel to LB media was a success in producing more MlrA enzyme from the same
volume. Even though the enzyme showed no activity after adding Ni, the enzyme was expressed
at a higher yield. Furthermore, it was to investigate adding methanol to the Sulfonated poly
(ether ether ketone) (SPEEK) membrane, which was used for the immobilization of MlrA, to
desorb the MC-LR from the membrane when doing the experiment of the immobilized MlrA.
Lastly, investigating the enzyme activity before and after enhancing the protein yield and
showing that adding the nickel will hinder the MlrA activity while the enzyme that produced in
the same conditions without Ni was active.
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1. Chapter one:
1.1 Introduction on MlrA:
Enzymes are proteins that help accelerate the chemical reactions in living organisms
(biocatalysts) by influencing the reaction speed by a million or more times (Berg, Tymoczko, &

Stryer, 2012). Microcystinase (MlrA) breaks down microcystin, a cyanobacterial toxin. MlrA is
an example of metalloenzymes, which uses a zinc ion as a cofactor in its active site (David G.
Bourne, Riddles, Jones, Smith, & Blakeley, 2001; Dexter, Mccormick, Fu, & Dziga, 2021).
MlrA is the first and the most crucial biodegradation step in the microcystin enzymatic
degradation pathway. Without MlrA, the cyclic microcystin-leucine arginine (MC-LR) will not
be linearized to continue the enzymatic degradation process. MlrA was first described in 1996
(D. G. Bourne et al., 1996), and its activity was proven to be specific to target the peptide bond
between the Adda group and the second amino acid in the MCs toxin (Dexter et al., 2021). Until
now, MlrA, MlrB, MlrC, and MlrD are the only enzymatic degradation pathway known to
eliminate MCs. There is currently an increased interest in this pathway from scientists to find a
novel alternative to industrial MCs removal from the water supply. MCs are cyanobacteria
products that provide an environment free from opposition bacterium and help cyanobacteria in
photosynthesis. In nature, MCs need 2 to 8 days for the degradation to start by other bacteria.
From this finding, researchers were able to identify bacteria that have the ability to neutralize the
cyanobacteria toxin. Also, researchers found the gene clusters that express the enzymes required
for the microcystin enzymatic degradation pathway. From the gene that was isolated from these
bacteria, the heterologous of the mlr gene in an expression vector was done to increase the
expression of the enzymes.
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1.2 Enzyme immobilization:
Enzyme immobilization is a technique where enzyme molecules are trapped in solid
support as a reactant, the substrate can pass through the enzyme, and the reaction will occur, later
the products can be collected (Sirisha, Jain, & Jain, 2016). It is widely used in the industry for a
few reasons like the product gatherer does not mix with the enzyme, so an additional technique
to separate the enzyme and the products are unnecessary (Homaei, Sariri, Vianello, & Stevanato,
2013). Enzyme molecules recover more rapidly when they are immobilized, so they are ready for
the following reaction. In a short time, immobilization also stabilizes the enzyme. So, they are
less likely to denature. There are several ways in which enzyme immobilization can be done.
These include adsorption, ionic bonding, covalent bonding, and entrapment method (Homaei et
al., 2013). An example of an enzyme immobilization vehicle is sulfonated poly (ether ether
ketone) (SPEEK) membranes. SPEEK membranes have an average hydrophilic property and stay
negatively charged in both acidic and basic conditions (Eke, Elder, & Escobar, 2018).

1.3 Bacteria stress:
E. coli can be stressed by its environment. This stress will force the bacteria to adapt to this
new condition or die (Washington – Hughes, Ford, Jones, Mcrae, & Outten, 2019). This stress
was caused by the low-intracellular iron levels in E. coli. Consequently, E. coli will maintain a
high expression of its iron uptake systems. Adding Ni to the LB media will cause this stress,
making the lag phase longer (Washington – Hughes et al., 2019). By using this property, the
MlrA enzyme could be expressed in a high quantity. This stress can be done by adding nickel to
LB media to enhance and increase the expression of mlrA gen in the host. Free nickel is toxic to
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E. coli (Kumar, Mishra, Kaur, & Dutta, 2017; Macomber & Hausinger, 2011; Washington –
Hughes et al., 2019); therefore, the right amount of nickel and time has to be determined to stress
the host. Since Ni is toxic to E. coli, the E. coli will start its response to the stress by expressing
its essential enzymes to prevent the death of the bacteria. Because Ni damages the DNA, E. coli
will try to start the SOS response, but Ni will prevent the SOS response in the bacteria (Kumar et
al., 2017), which means that bacteria resources may become available to the heterologous
enzyme of interest in this case, MlrA. By adding 1.4 mM Ni to the growth culture after 30 min
from adding the IPTG, E. coli is at its highest activity in the logarithmic phase, which can, in
theory, redirect the cell resources to the expression of MlrA. The choose of the Log phase was
passed on the previous study on E. coli stress (Chung, Bang, & Drake, 2006). Nickel stress will
force E. coli to increase its metal concentration instead of having the minimum limit for its
enzymes (Macomber & Hausinger, 2011; Washington – Hughes et al., 2019). This accumulation
of vital metals to E.coli would be done during the lag phase if the Ni was added during this phase
(Rolfe Matthew et al., 2012).
MlrA is a zinc metalloprotein, and zinc is one of the metals that can be stored at a higher
level inside the bacteria during stress. The second possibility is that nickel may substitute zinc in
MlrA or bind at the MlrA on another site; it may also inhibit MlrA activity (Macomber &
Hausinger, 2011). So, increasing the zinc concentration and overexpressing the host enzymes can
lead to high MlrA concentration in the enzyme expression process.
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2. Chapter 2: Literature Review:
Microcystin (MC) is a harmful natural bacteria product, and it is contaminating water
supplies worldwide. For example, the city of Toledo, Ohio, shut down its entire drinking water
system in 2014 because of a cyanobacterial bloom (Steffen et al., 2017). MC contamination is
occurring at a fast rate due to global warming and an environment rich in nutrients like nitrogen
and phosphorus (Liu et al., 2020; Martínez-Ruiz & Martínez-Jerónimo, 2016). Nitrogen and
phosphorus are nutrients that are natural parts of aquatic ecosystems. Nitrogen and phosphorus
support the growth of algae and aquatic plants, which provide food and habitat for organisms that
live in water.
Furthermore, phosphorus and nitrogen are in an overflowing supply because of pesticides
and fertilizers in agriculture. In addition, phosphorus and nitrogen come from water treatment
plants. For these reasons, freshwater cyanobacteria producing MC started to colonize
environments where the bacterium did not exist (Wilken, Wiezer, Huisman, & Van Donk, 2010).
Consuming water that is contaminated with MC can cause cancer or even death. Many
studies were done to study and eliminate MC toxicity from the environment. There are around
250 types of MC, but MC-leucine-arginine (MC-LR) is the most toxic type of MC and is widely
available in water sources around the world (Dexter et al., 2021; Yang et al., 2020). MCs are a
group of cyclic heptapeptides that contains D-alanine, D-erythro-b-methylaspartic acid, Adda, clinked-D-glutamic acid, N-methyl dehydroalanine, and two-variable L-amino acids (Chang et al.,
2015; Dexter et al., 2021).
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There are many ways to degrade MC-LR that are used today. There is a physical treatment,
chemical treatment, and biological treatment. All these treatments cannot degrade MC toxicity
completely or have side effects (ref).

Leu
Arg

Figure.1: MC-LR cyclic structure
Physical treatment can remove cyanobacteria from water, but it cannot remove MC.
Chemical treatment has selectivity against MC types, and it cannot mitigate the toxicity
completely. Biological treatment can remove the bacteria and its toxin. Introducing a new
bacterium that can degrade MC toxic may produce an unknown threat to the environment, or the
new species can colonize the ecosystem and become a new threat to existing species. A new way
to degrade MC is by using enzymatic degradation. Microcystinase A (MlrA) is an enzyme that is
produced by some bacteria that can degrade MC. According to Liu et al., these bacteria strains
were identified and found that MC degradation is not sufficient to mitigate the high
5

concentration of MC (ref). For that reason, cloning the gene into bacteria that can produce high
MlrA concentration is this research focus.

2.1 MC characteristics:
MC gains attention because it is poisonous to humans and animals, and lower doses of MC
cause cancer in humans (Wei et al., 2021). MC is a chemically stable molecule that can endure
high temperatures and different pH levels, and for that reason, it resists traditional water
treatments (Dexter et al., 2021; Li et al., 2017; Qin et al., 2019). Once cyanobacteria release the
MC into the aquatic system, it exists for 2-3 weeks before the natural biodegradation process
starts (David G. Bourne et al., 2001; Jones & Orr, 1994). MC is named according to the amino
acids on positions 2 and 4. For example, MC-LR (Microcystin – Leucine Arginine) is named
according to leucine (L) and arginine (R) located where reference figure 1. Cyanobacteria
produced MCs to enhances their ability to live and establishing their colonies (Gan et al., 2012).
MC is able to affect algae growth and makes a zone free of algae, so it eliminates the
competition throughout the area the cyanobacteria colonized by using two methods. The first
way is that the extracellular MC protects the bacteria from its competition in the ecosystem.
Furthermore, intracellular MC enhances the cyanobacteria's photosynthesis process and makes it
more resistant to environmental stress (De Figueiredo, Azeiteiro, Esteves, Gonçalves, & Pereira,
2004; Qin et al., 2019).
MC is synthesized through amicrocystin synthetase complex (mcy-genes) on the
cyanobacteria, and it is an ATP-dependent reaction. It can be a nitrogen reserve for
cyanobacteria and regulate protein synthesis. Many factors play a role in MC's production, like
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light type, temperature, and nitrogen and phosphorus concentration (De Figueiredo et al., 2004).
Some studies found that red light makes M. aeruginosa PCC7806 produce more MC, while blue
light lowers the MC production rate (De Figueiredo et al., 2004; Kaebernick, Neilan, BöRner, &
Dittmann, 2000; Rapala, Sivonen, Lyra, & Niemelä, 1997).
The temperature has an effect on the type of MC toxin to be produced, low temperature
favoring MC-LR synthesis (De Figueiredo et al., 2004; Rapala et al., 1997). On the other hand,
higher than 25C, the cyanobacteria will favor MC-RR synthesis (De Figueiredo et al., 2004;
Rapala et al., 1997). Cyanobacteria that produce MC vary in response to the concentration of
nitrogen and phosphorus. Some will be affected, like the non-nitrogen-fixing cyanobacterium M.
aeruginosa. M. aeruginosa will be affected by the limited nitrogen while growing. Consequently,
the effect is smaller than the usual cell size and higher intercellular MC production. Microcystis
spp. and M. aeruginosa can produce more MC in higher phosphor concentrations (De
Figueiredo et al., 2004).

2.2 MC-LR degradation:
The microcystin-degrading bacterium is a new strategy to eliminate MC in the environment.
This method can be safe for the environment and can be done on a vast scale. Yang et al. were
able to identify a new native bacterium called Sphingopyxis sp. YF1, with a high MC-degrading
rate in lake Taihu. The degradation process starts with MlrA, which linearizes MC-LR by
cleaving the peptide bond between Adda and arginine. The second enzyme, MlrB, produces
tetrapeptide from the linear MC-LR. The third enzyme, MlrC, frees the Adda group from the
tetrapeptide produced by MlrB or the linearized MC-LR produced by MlrA. The final enzyme in
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the mlr cluster is MlrD, which is believed to be a membrane transporter enzyme that moves
Adda through the bacteria cell wall. After the Adda group is freed from the tetrapeptide,
phenylacetate (paa) cluster enzymes further degrade Adda to CO2 in the TCA cycle (Yang et al.,
2020).
Also, chemical treatment with MlrA is another method that is used to kill cyanobacteria in
the water supply and degrade MCs. Treatment of cyanobacteria by Hydrogen Peroxide (H2O2)
was questionable, but after adding MlrA to this treatment, both Cyanobacteria and Mcrosystien
were eliminated, and the treatment has great potential. The treatment by H2O2 alone reduced the
MC concentration in the water quickly by killing the bacteria. Still, the problem is that bacteria
can enhance their ability to adapt to H2O2 and become resistant. Fortunately, MC-producing
bacteria is less resistant to H2O2 (Dziga et al., 2019). After combining MlrA with H2O2, H2O2 will
lysate the cyanobacteria. Within the lysate, MC-LR is presented, MlrA will cleavage the MCLR. Also, they emphasize the temperature and the pH level MlrA can work in (Dziga et al.,
2019).
Physical treatment has limitations in removing the MCs from water. Traditional water
treatments like chlorination, activated carbon adsorption, and membrane separation can remove
the cyanobacteria from the drinking water, but once the toxin is released into the water, these
treatments cannot eliminate it (Liang et al., 2021). The current method uses Fenton-based
technologies to eliminate MCs, and the drawback is that it is costly and the process consumes
high energy (Liang et al., 2021).
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2.3 MlrA characteristics:
One of the ways to remove MC is to use enzyme degradation. This pathway occurs naturally
in the environment by some bacteria that are able to degrade MCs. From these bacteria, scientists
found that there are four enzymes involved in MC degradation: MlrA, MlrB, MlrC, and MlrD
(Qin et al., 2019). MlrA is believed to be a metalloprotease. The metalloproteases are a
significant class of enzymes that cleavage peptides. These enzymes have metal ions in their
active site, mostly is zinc ions. These ions stabilized the amino acids in the active site to attack
the peptide carbonyl group in MC-LR and insert a water molecule. Still, two recent studies
suggested that it is an intramembrane glutamate protease, and it belongs to type II CAAX prenyl
endopeptidases (David G. Bourne et al., 2001; Dexter et al., 2021; Xu et al., 2019).
MlrA is identified as metallopeptidases based on inhibition by metallopeptidase inhibitors
EDTA and 1,10-phenanthroline. Also, MlrA active sites are very similar to metalloproteases
active sites. From the MlrA protein sequence, the region H260 AIH263 NE265 of MlrA contains
the active sites with this sequence valine(a)-bXHbbHbEc (Bourne et al., 2001; Dexter et al.,
2018). In figure 2b, MlrA was modeled using the phyre2 model, and it showed 100% confidence
and 74% sequence coverage. Histidine and glutamic acid work by hydrolyzing the cyclic form of
MCs and inserting a water molecule. Also, MlrA is able to affect MC-LR producing mcy genes
and lower the transcription rate of MC-LR in the cyanobacteria. Hence, by reducing the MC
production, the bacteria will decrease in numbers (Liu et al., 2020). MlrA initiates the MlrABC
degradation pathway (Dexter et al., 2018) by linearizing MC-leucine-arginine (MC-LR). MlrA
cleavage the peptide bond between Adda and arginine. This cleavage will remove around 60% of
MC-LR toxicity (David G. Bourne et al., 2001; Dexter et al., 2018; Dexter et al., 2021; Kormas
& Lymperopoulou, 2013; Liu et al., 2020; Yang et al., 2020).
9

A

Glu 265

His 260, 263

B

Figure.2: A: MlrA protein modeling showing the active site. B: showing the confidence in the
modeling by Phyre2. Image by the author using (Kelley, Mezulis, Yates, Wass, & Sternberg,
2015).
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While looking for a new way to enhance MlrA yield, a study done by Jiang et al. found that
adding MC-LR to LB media while expressing the enzyme stimulates and increases the protein
yields. They started with 0.4mg/l MC-LR added to LB media, and they saw a slight increase in
mlrA gene transcription, which led to more protein yields. The higher increase in mlrA gene
transcription was after adding 2mg/l MC-LR to LB media. This increase happened after
45minets of adding the MC-LR. This finding proves that the mlrA gene is responsible for
detecting the cyanobacteria toxin and responding to its presents (Jiang, Shao, Wu, Xu, & Li,
2011).
Wu et al. immobilized MlrA by adding L-cysteine and Graphene Oxide to the enzyme and
extended the lifetime of the enzyme. Consequently, increasing MlrA usability to degrade MC-LR
(Wu et al., 2020). Liu et al. were the first team to reach more than 90% MlrA purity. MlrA is one
of the most problematic proteins to purify (Liu et al., 2020); for example, MlrA is hard to fold
correctly when expressed in the host cell (Liu et al., 2020). When expressed MlrA in the host
cell, Liu et al. added a Maltose-binding protein tag (MBP) to MlrA. MBP-tag kept the protein
soluble and reduced protein degradation. These properties make the MBP-tag an excellent
candidate for obtaining the pure MlrA. The fused MlrA showed higher activity against MC-LR,
RR, and YR than MlrA without MBP-tag (Liu et al., 2020).
Bourne et al. characterized mlr gene cluster in a study published in 2001. They stated that
both MlrA and MlrC are homologous, and they are metalloenzymes. They were both repressed
by EDTA but not MlrB. MlrD is a transporter enzyme that transfers the Adda group within the
cell wall of the bacteria. Moreover, they have given the molecular weight for each enzyme
product: linearized MC-LR weight 1012 Da, which is MlrA product, tetra-peptide weight 614
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Da, which is MlrB product, but they did not identify MlrC product, which later described in the
literature as Adda group (David G. Bourne et al., 2001).
In the literature on MlrA purification and expression, most methods need some stabilization
to be attached to the enzyme. Either protein tag like Maltose Binding Protein tag or the enzyme
needs to be immobilized like adding L-cysteine and Graphene Oxide to the MlrA. This finding
raises a question in expressing the MlrA, is the protein tag play a massive role in its stability and
activity?

2.4 Bacteria stress in this experiment:
In this experiment, Ni was added after adding the IPTG to the growth with Ni by 30 min. The
reason for adding the Ni after 30 min is to ensure that the E. coli started the expression of the
mlrA gene, and it is in the Log phase.

3. Chapter 3: MlrA expression and purification
3.1 Project objectives:
This study aimed to demonstrate the effect of adding nickel on the protein yield, demonstrate
absorption and desorption of MC-LR to SPEEK membranes to use the membranes in future
study, and investigate the activity of free MlrA.
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3.2 Materials and Methods:
3.2.1 Strain and plasmid construction:
E. coli BL21 was purchased from New England Biolabs. The plasmid pET-21a (+),
which has 5369 bp, was purchased from Novagen Life Technologies. Finally, a recombinant
pET-MlrA plasmid, which has 6417 bp, was constructed and transformed into E. coli BL21. In
this experiment, the 1048 bp mlrA gene was transferred to E. coli competent Bl-21with the heat
shock method as part of the plasmid. The process started by using two tubes, one for pET
plasmid containing 10 µl of 500mg/µl pET-21a plasmid. The second tube has 2 µl of mlrA DNA.
Both tubes have 1.25 µl of BamHI 10 U/µL and XhoI 10 U/µL, which are restriction enzymes to
cleave the pET plasmid and mlrA gene. Then, 17 µl water and 2.5 µl of 10X digestion buffer
were added to both tubes. After incubation for 1 hour at 37°C, incubation for 5 minutes was done
at 65°C to denature the enzymes.
By using 20 μl of recovery buffer, the cleaved gene and plasmid were recovered from the
agarose gel. After retrieving the mlrA DNA and the plasmid, 10 µl of the plasmid, and 2 µl of
mlrA DNA were incubated overnight with 1 µl of 5 U/μL T4 DNA ligase enzyme, 2.5 µl of 10x
ligase buffer, and 1.5 µl of DI water. After the incubation, 5 µl of the ligation solution was added
to 50 µl of media containing competent E. coli BL21. The E. coli and the plasmid were placed on
ice for 30 minutes, then incubated for 10 seconds at 42°C then returned on ice for 5 min. Then
1ml of SOC outgrowth medium (New England, Biolab USA) was added to the tube containing
the heat-shocked E. coli BL21. After mixing the E. coli with SOC media, the mixer was
incubated for 2 hours at 37°C, and then 100 µl was spread on an (LB) agar plate containing 100
µl/ml of ampicillin at 37°C overnight.
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3.2.2 Expression of MlrA:
LB media was used to grow the host bacteria to express the enzyme. A10 ml of LB media
was used as an overnight culture, containing 10 μg/ml ampicillin, and was inoculated with a
swap of one colony of E. coli. The overnight culture was incubated at 37° C with shaking at 200
rpm. Then, the overnight growth was transferred to 1L of LB media that contained 75 μg/ml
ampicillin and was incubated at 37°C with shaking at 200 rpm until the optical density (O.D.) at
600nm reached 0.6-0.8. After reaching the OD at 0.6-0.8, 100 μg/ml, isopropyl β-D-1thiogalactopyranoside (IPTG) was added to the culture. For a culture with nickel sulfate, 1.4mM
nickel was added after adding the IPTG for 30 min. After around 4 hours from adding the IPTG,
cells were collected by centrifugation for 1 hour at 3750 rpm.

3.2.3 Cell lysate and protein purification:
After harvesting the cells, the cell pellets from 1L culture were resuspended in 10 ml of 5
mM sodium phosphate buffer, pH 7.4. The resuspended cells were sonicated at low amplitude
using 5-second pulse and 5-second rest cycles for 15 min in an ice bath. The supernatants were
then centrifuged for 1 hour at 3750 rpm, a second centrifuge process for 10 min at 13000 rpm
was done. The lysate filtration was made by a 0.22 μm syringe filter. Furthermore, the
purification was done using the Fast Protein Liquid Chromatography (FPLC) system from
ӒKTA. The column, which was from GE Healthcare-Bio-Sciences, was cobalt loaded Hi-Trap
Immobilized Metal Affinity Chromatography (IMAC) column to purify the 6x His tagged MlrA
protein. Histidine had an imidazole ring that would bind to the metal ions of the column, in this
case, cobalt. The sodium phosphate buffer had 250mM imidazole with pH=7.3. After running the
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buffer in the FPLC, the imidazole would compete with the protein and replaced it in the column.
The elution would have MlrA. The fractions collections process was set up to have 5 ml of the
eluted buffer in each fraction, and the column size was 5 ml. However, before going further,
buffer exchange would be made by using a low salt buffer, in this case, 5 mM sodium phosphate
buffer, 15 ml for every 5 ml fraction. After buffer exchange, protein fractions would be subject
to sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE).

3.2.4 Concentration determination:
The concentration of the MlrA was determined by using a derived form of the BeerLambert Law. The molecular weight and extinction coefficient were determined from the MlrA
sequence, which was
mrefvkqrpl
ypgaytlllf
ffaltgimwv
lpqllkkfdp
iavfvcnklg
cgrslgaasp

lcfyalaili
paapmlaali
qtylyappgt
laaavilglm
gsmwggvlih
dnarlawgnv

altahalram
vtgigygrsg
ldrtflrygs
wwawhlprdl
aihnelgvnv
ppklpggatd

sptplgpmfk
frellsrcap
dpvaiymmla
ptlfsgepga
taewaptvag
ksgana

mlqethahln
wrspvswrqg
aslllspgpl
awgvivkqfv
lgwrpwdlve

iitavrstfd
vtviavcfla
leelgwrgfa
iipgfiagti
favaiglvli

61
121
181
241
301

From the sequence, MlrA had 8 tyrosine, 13 tryptophan, and 5 cystine. By using this formula
𝐸𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 = ( 𝑛𝑊 𝑥 5500) + (𝑛𝑌 𝑥1490) + ( 𝑛𝐶 𝑥 125), the
extinction coefficient would be determined. Also, the protein absorbance at 280nm was
measured using Shimadzu UV-2600 Spectrometer.
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3.2.5 Preparing samples for metal analysis:
Inductively coupled plasma mass spectrometry (ICP-MS) was used for analyzing nickel
and zinc on the protein. The sample was diluted by 1 to 10 dilution factors using dilute acids. For
example, 1 ml of concentrated MlrA + 9 ml of 2% nitric acid. A dilution factor from 10 to 50
was usually acceptable for liquid protein (Wilschefski & Baxter, 2019). ICP-MS was used to
determine the metals present on the enzyme, for example, nickel, zinc, and to compare enzymes
from different growth conditions.

3.2.6 MlrA activity experiment:
For the enzyme activity assay, MC-LR was treated with MlrA, and the activity was
checked at three intervals of 0, 4, and 24 hours. 1325 μL 5mM sodium phosphate buffer was
added to a 20 ml glass vial, then 475 μL of MlrA enzyme was added. Finally, 200 μL MC-LR
solution (1 mg/L) was added as the final step of the reaction. The final volume was 2 ml with a
final concentration of 0.216 mg/ml of MlrA in the solution. The reaction was stopped by the
addition of 50 μL 5% acetic acid to 500 μL of the solution at 0, 4, and 24 hours. After collecting
the samples, they were analyzed by High-performance liquid chromatography (HPLC).

3.2.7 FTIR for SPEEK membranes:
SPEEK offers high proton conductivity (Daud et al., 2021), and MlrA was a positively
charged enzyme. The enzyme was attached to the SPEEK membrane to be used on the enzyme
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activity as an immobilized enzyme. Fourier transform infrared (FTIR) was used to detect the
presence of the MlrA enzyme on SPEEK membranes after immobilization.

3.2.8 Absorption and desorption of MC-LR to SPEEK membranes:
MlrA was immobilized to SPEEK membranes followed by incubation with MC-LR the
same as other experiments. Therefore, this experiment was designed to confirm the absorption of
MC-LR to the membrane and to try to desorb it back from the membrane. 200 μL MC-LR (10
μg/L) was added to 1800 μL phosphate buffer (5 mM). All was added over a control SPEEK
membrane. Before taking the sample after 24 hours, 667 μL methanol was added. Like the free
MlrA experiment, samples were taken after 0, 4, and 24 hours.

3.3 Result and discussion:
3.3.1 Cloning results:
Figure 3 shows the plasmid on lines 2 and 3, which had 5403 bp, and the mlrA gene,
which had 1048 bp, on lines 5, 6, and 7, which was used as described on the plasmid
construction step. After the cloning was done, plates containing ampicillin showed colonies
indicating the successful cloning of the plasmid pETMlrA, which had 6451 bp into the E. Coli.
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Figure.3: lane 1) standard DNA Ladder starting from 4000 bp to 100 bp. Lane 2) pET plasmid
uncut 5443 bp. Lane 3,4) pET plasmid cleaved 5403 bp. 5,6,7) mlrA gene cleaved 1048 bp.

3.3.2 Purification results:
A gradient of 250mM imidazole buffer was used. At 62.5mM imidazole, the majority of
MlrA was eluted. At 125mM imidazole, a small peak was formed; these fractions had a lower
MlrA concentration. At 187.5mM and 250mM imidazole, low or no trace for MlrA was found.
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Figure.4: FPLC graph showing the peaks from which the fractions were collected. MlrA was
eluted after 43ml until around 75ml. The peak at 43ml was using 62.5mM imidazole, and the
peak around 73ml was using 125mM imidazole.

3.3.3 SDS-PAGE result:
Results showed a band at around 42 kDa to indicate the presence of MlrA (Figure 5a).
The arrows indicate the band that formed from the fractions that were selected. The higher the
concentration of imidazole, the more enzyme purity obtained. Fractions 5, 6, and 7 were from
62.5mM imidazole, and they showed a higher enzyme presence than what was presented at
fraction 10 from 125mM imidazole.
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Figure.5a: SDS-PAGE gel showing the bands with MlrA around 42 kDa from the fractions from
the FPLC. L=Lysate, F.T.= Flow-through, 5, 6, 7, and 10 are the fractions numbers.

For the Ni growth, MlrA was expressed at a higher yield and higher concentrations
(Figure 5b), which indicated that the bacteria were indeed under the stress of the added Ni. After
three experiments, the average enzyme concentration was higher when Ni was added. The
average concentration for Ni growth is 1.26 mg/ml. In comparison, the normal growth was
averaged around 1.097 mg/ml from the same volume. MlrA bands were clearly visible in the
SDS-PAGE gel, especially in 125mM imidazole lane 11. This clarity was noticeable when
comparing lane 10 from figure 5a with lane 11 from figure 5b. Table 1 shows the concentration
from each growth, and the MlrA concentration was the average of the three experiments. MlrA
expression with Ni had the higher concentration. Even though the differences were not
significant, the concentration on MlrA yield was higher in every growth with Ni.
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Figure 5b: MlrA from growth with Ni. Lanes 7 and 8 are from 62.5mM imidazole, lane 11 is
from 125mM imidazole.

Table 1: showing the individual concentration for each growth. Fractions from 125mM
imidazole were not included in the experiments averaging.

Growth volume

MlrA concentration

1L MlrA
1L MlrA +Ni

0.892 mg/mL
1.16 mg/mL

1L MlrA
1L MlrA+Ni

1.17mg/ml
1.24 mg/Ml

1L MlrA
1L MlrA+ Ni

1.23 mg/mL
1.38 mg/mL

21

3.3.4 MlrA activity result:
After confirming the presence of MlrA using SDS-PAGE, 5mM sodium phosphate buffer
was used for the buffer exchange and to concentrate MlrA. The activity experiment was done as
described in the methods section. MlrA showed the ability to degrade MC-LR after 24 hours. A
new peak was shown at m/z 1010.1 on the HPLC figure 6a, which was not shown in the control
experiment of figure 6b. Cyclic MC-LR was at m/z 995.6, while linearized MC-LR was at m/z
1010.1. Also, it was clear that not all the MC-LR was degraded, which suggests that the enzyme
needs more time to degrade the toxin. As described, the samples were taken at 0, 4, and 24 hours.
Only the sample at 24 hours showed the linear MC-LR. The experiment with the enzyme grown
with added Ni showed that the enzyme was inactive even though the enzyme had a higher
concentration (1.16 mg/ml) than the regular enzyme, which was 0.892 mg/ml. Because the graph
of the activity experiment with added Ni was similar to the control, the graph of the activity
experiment with added Ni was not shown.
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Linear MC-LR

Figure 6a: Electrospray ionization (ESI) MS analysis of the cyclic MC-LR. After 24hrs of the
treatment with the MlrA enzyme, linearized MC-LR was produced at m/z 1010.1 (5.91 mint MS
run).

MC-LR

Figure 6b: The control was only MC-LR and 5mM sodium phosphate buffer. The control run that
only showed MC-LR at m/z 995.6.
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3.3.5 FTIR results:
From figure 7, at around 1700cm-1, carbonyl stretch was present in both the control (blue
graph) and the SPEEK_MlrA membranes (orange graph), but the intensity of the stretch was
lower in SPEEK_MlrA around 1750cm-1. Additionally, before 3000cm-1, there was a saturated
CH stretch from around 2750cm-1 to around 3600cm-1, the IR was absorbed by the
SPEEK_MlrA more than the control SPEEK, indicating that the enzyme is attached to the
membrane. Generally, the membranes had similar absorbance behavior.

Carbonyl stretch around
1700cm-1

CH stretch from around
2750cm-1 to around
3600cm-1

Figure 7: showing FTIR graph of SPEEK_control without MlrA in blue and showing
SPEEK_MlrA in orange.
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3.3.6 Absorption and desorption of MC-LR to SPEEK membranes results:
The results showed that adding methanol to the membrane was successfully desorb MCLR. At 0 hours, figure 8a showed the toxin peak at around 5 min. Figure 8b showed how the
SPEEK membrane absorbed the toxin. The HPLC reading was lower than the reading from 8a.
Figure 8c shows how methanol desorbs MC-LR from the membrane. The peak returned to its
expected peak.

MC-LR

Figure 8a: At 0 hours, there is no absorbance to the SPEEK membrane.
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MC-LR

Figure 8b: At 4 hours, a small peak at 5 min indicates that MC-LR was absorbed by the SPEEK
membrane.

MC-LR

Figure 8c: At 24 hours shows that the MC-LR is desorbed from the SPEEK membrane.
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3.3.7 Metal analysis results:
Because MlrA has a zinc-binding site, zinc concentration was higher than the nickel in all
experiments. When buffer exchange was done, it was made by three times the volume of the
samples to make sure to remove any residues in the samples. From table 2, nickel presence was
high in samples from growth with Ni, and Ni existed in low concentration in non-Ni growth.
Zinc concentration was high regardless of the growth type, and it correlated to the enzyme
concentration. It is clear that the Ni did not substitute the Zn. From the MlrA activity experiment,
the enzyme with the addition of Ni was not active. That may indicate that the Ni was attached to
the enzyme on the active site directly like a competitive inhibitor, or it may act as a noncompetitive inhibitor to MlrA and attached on another site, and by attaching to a different site, Ni
change the three-dimensional structure, and the enzyme becomes inactive.
Table 2 Concentration of Zn and Ni in MlrA samples.

Sample concentration
MlrA +Ni = 1.16 mg/ml
MlrA Con= 0.892 mg/ml
MlrA Con=0.411 mg/ml

Ni
202.2ppm
33.8ppm
34.02ppm

Zn
581.3ppm
504.2ppm
127.9ppm

3.4 Conclusion:
In this study, an active MlrA enzyme was produced from a heterologous host, and the
enzyme was able to degrade MC-LR and convert it to linearized MC-LR. Also, adding nickel to
LB media increased the protein yield in E. coli. Even though the enzyme after adding nickel was
not active, non-metalloenzyme could benefit from this method in the future. Additionally,
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investigating how to desorb MC-LR from SPEEK membranes can help in the future with the
experiment of immobilized MlrA to SPEEK membrane.
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Appendix
Investigating Microneedles releasing High Molecular Weight Proteins.
Abstract
This study was to investigate poly (vinyl alcohol) (PVA) as a microneedle to release a
large molecular weight protein using PspA protein as a drug model. The release from the
microneedles was successfully obtained, confirming a controlled release of PspA protein over
time. From the successful release of the PspA protein, a similar weight protein can be used.

1. Introduction on PspA:
According to the CDC, pneumococcal diseases occur worldwide, especially in lowincome countries where vaccines are limited or unavailable. PspA, a surface protein of
Streptococcus pneumoniae, is the next generation of pneumococcal vaccines (Baril et al., 2006).
PspA is an antigen that provides stimulation to the immune system to fight pneumococcal
diseases. Also, the PspA vaccine will protect against pneumococci of more than one capsular
type (L. S. Mcdaniel, Sheffield, Delucchi, & Briles, 1991). PspA is naturally expressed on the
surface of most pneumococci types, and it helps the pneumococci to colonize the respiratory
tract. pspA gene has variable sequences in different pneumococci. Because of the gene
variations, PspA protein has different amino acid sequences and molecular weights (Baril et al.,
2006).
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2. Incorporating PspA in microneedles and microneedles fabrications:
Streptococcus pneumoniae is a gram-positive bacterium. Hence, like many gram-positive
bacteria, S. pneumoniae infections are hard to be treated (J. Jedrzejas, Ejvis Lamani, &
S. Becker, 2001). S. pneumoniae colonizes the upper raspatory tract in humans (J. Jedrzejas,
2001; Moore, Bosarge, Quin, & McDaniel, 2006). Also, it affects more than 100,000 people in
the United States each year, causing more than 40,000 deaths from this infection, especially in
the elder population (Briles et al., 1998; Moore et al., 2006). In developing countries, mortality
from Streptococcus pneumoniae is usually in children of five years or younger. PspA is found
on the surface of all pneumococci bacteria. The function of PspA is to help the pneumococci
colonize and affect the host (Moore et al., 2006).
Developing vaccines can be done by using the same antigen that causing the disease. The
vaccine can stimulate the immune system to identify the antigen and develop an antibody against
it. PspA is what makes the Streptococcus pneumoniae attached to human lactoferrin and
interferes (Baril et al., 2006). By administering the PspA protein as a vaccine, PspA will
stimulate the host to develop an immune response, making the body develop antibodies to
Streptococcus pneumoniae (Baril et al., 2006). There are 5 clades for the PspA from 2 families.
Hence, the variation in the PspA protein molecular weight. From the 5 clades, clade 2 from
family 1, 3, and 4 from family 2 protects against most pneumococcal strains (Baril et al., 2006).
The alpha-helix domain of PspA can trigger the protection against Streptococcus pneumoniae;
from this alpha-helix domain, a fragment of around 38 kDa is used in many studies (Aljewari et
al., 2020).
Due to the degradation or low absorption in some drugs, some drugs have to be
administered intravenously or subcutaneously if taken orally. The conventional injection can
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deliver drugs through the skin, but this method is limited to lipophilic and low molecular weight
drugs (Gill & Prausnitz, 2007). Hence, a low-cost and safe method of administering drugs should
be developed. Pathological science has shown that the skin is full of immune cells and scientists
now know that this is a suitable area for the application of vaccines and other drugs. The
pharmaceutical industry is trying the outstanding possibility of using microneedles, and they are
working on a new process to turn the whole concept of microneedles into a commercially viable
reality. Microneedles can be developed using different materials like Polyvinyl alcohol (PVA),
plastic, and stainless steel. PVA was chosen because of its biocompatibility, and PVA is noncarcinogenic (Kamoun, Chen, Mohy Eldin, & Kenawy, 2015).
Microneedles were first introduced in the 1970s, and it was handmade. In the late 1990s,
with the nanotechnology advancements, microneedles gained more attention by scientists as a
way to deliver drugs that required a direct injection to the bloodstream due to its low absorbance
in the digestive system and without puncturing the skin like conventional needles (Kim, Park, &
Prausnitz, 2012; Prausnitz, Mitragotri, & Langer, 2004). Many types of microneedles were
introduced, like coated microneedles, hollow microneedles, and hydrogel microneedles (Gill &
Prausnitz, 2007). Also, microneedles can eliminate the high cost of qualified staff to administrate
the microneedles since they stack to the skin and do the release. This cost-saving is essential in
low-income countries and countries with limited health care infrastructure.
One type of microneedles is the premade microneedles. These microneedles can be
coated with a drug to be administered to the skin (Gill & Prausnitz, 2007). The downside of this
method is that the microneedles can lose the drug during administration. Therefore, the coating
process can lower the sharpness of the tip and waste materials because of the added coating
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layers (Gill & Prausnitz, 2007). Also, the microneedle that was used in Gill and Prausnitz's study
was made of stainless steel.
Another type is hollow microneedles. Those made with silicon are currently in use in
healthcare monitoring technologies, and the Food and Drug Administration (FDA) has granted
its use (Li et al., 2019). One of the properties of silicon-based microneedles is their ability to
penetrate the skin and not break inside. Nanosensors can be fitted inside Hollow microneedles
that are silicon-based, which monitor the individual health for a long time without irritation.
Microneedles are fabricated with different materials, stainless steel, plastic, silicon.
However, a low-cost and improved property alternative can be found in polymeric microneedle
(Castilla-Casadiego et al., 2021). Polymeric microneedles can control the drug release over time
with the microneedle degradation in the skin. PVA and chitosan are examples of polymeric
microneedles. They are both biocompatible, non-toxic, and relatively low-cost (Aljewari et al.,
2020; Castilla-Casadiego et al., 2021).
PVA gels that were crosslinked with glutaraldehyde can absorb water because of their
high degree of swelling in an aqueous solution (Agarwal, Alam, & Gupta, 2013). This absorption
causes the PVA gel to control the release of the protein incorporated in the gel in hydrophilic
buffers (Aljewari et al., 2020). This property of PVA gel makes it an excellent candidate for
using it in many studies (Aljewari et al., 2020). Furthermore, PVA gels can make the drug
completely available to be discharged. Also, PVA is non-biodegradable, which makes PVA
stable when releasing the drugs for a long time.
After isolating the pspA gene, it was cloned into a heterologous host, in this case, E. coli.
After the enzyme expression, PspA protein was used as a vaccine. PspA protein showed its
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ability to prevent many infections caused by S. pneumoniae (Briles et al., 1998; Moore et al.,
2006; Saumyaa et al., 2016). PspA is a significant protein, and its molecular weight can go up to
130kDa (L. Mcdaniel et al., 1997). Hence, fragments from PspA protein were used in many
studies instead of the whole protein, including this study. The goal of this study is to confirm the
release of the PspA vaccine via microneedles. The microneedles were fabricated using Polyvinyl
alcohol (PVA). PVA is biocompatible; as a hydrogel, PVA is used in many medical and
engineering applications. PVA can be dissolved in water and can be crosslinked using
Glutaraldehyde (GA) (Sana Ullah et al., 2020). GA is a known agent for crosslinking polymers.
PVA, as a crosslinked hydrogel, can not dissolve in water, making it an excellent candidate for
microneedles fabrication (Aljewari et al., 2020).

Microneedle fabrication:
3. Project objectives:
Investigate PVA microneedle as an ideal carrier for large proteins by using PspA as a
drug model.
4. Microneedle fabrication with PspA:
4.1 Material and methods:
The hydrogels used for this study were prepared using poly (vinyl alcohol) PVA (98%
hydrolyzed, the molecular weight of 70,000 - 100,000 g/mol−1), acetic acid (AA), and
glutaraldehyde (GA) (50% aqueous solution). All materials for the formation of membranes were
purchased from Sigma-Aldrich chemical company (St. Louis, MO, USA). Ampicillin was also
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purchased from Sigma-Aldrich chemical company. Sodium phosphate and Luria broth were
purchased from Fisher Scientific (ThermoFisher Scientific, USA). All chemicals were used
without further purification and were of analytical grade. The alpha-helical domain of PspA was
purified from the E. coli clone.

4.2 Growth and purification of PspA:
A10 ml of LB media was used as an overnight culture, containing 10 μg/ml ampicillin, and
was inoculated with a swap of one colony of E. coli. The overnight culture was incubated at 37°
C with shaking at 200 rpm. Then, the overnight growth was transferred to 1L of LB media that
contained 75 μg/ml ampicillin and was incubated at 37°C with shaking at 200 rpm until the
optical density (O.D.) at 600nm reached 0.6-0.8. After reaching the OD at 0.6-0.8, 100 μg/ml,
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the culture. After four hours of the
induction with IPTG, bacteria were collected and centrifuged for one hour at 3750 rpm at 4°C.
Pellets were resuspended with 10ml of 10mM sodium phosphate buffer at 7.4 pH for each oneliter growth broth. The cells were sonicated for 15 min, 5 seconds pulse, 5 seconds rest at 20%
power in an ice bath. After the sonication, the lysate was centrifuged for one hour at 3750rpm at
4°C. Then, the microcentrifuge was used to separate the lysate further. The microcentrifuge
setting was 13000rpm for 5min. Affinity chromatography (FPLC) was used to purify PspA.
SDS-PAGE was used to confirm protein purity and the PspA molecular weight, which is 37kDa.
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4.3 Microneedles with the PspA protein:
Microneedles were fabricated by adding 5g of PVA powder to 40ml of distilled water at
boiling temperature. Then, 960µl of PVA and 250 μl of PspA was added to a small vial which
contained a Stirring bar to mix the solution, 108.75μl of 10% sulfuric acid was added as a
catalyst, 36.25μl of 10% acetic acid was added as a buffer, 36.25μl of 50% methanol was added
as a reaction stopper. Finally, 108.75μl of 1% GA was added as a crosslinker. After 15 seconds,
the mixer was brewed to prefabricated microneedle molds, and the molds were left for 6 hours to
crosslink at room temperature.

Figure 7: Microneedle after it was made under the light microscope.
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4.4 The diffusion cell experiment:
Microneedles were placed between the three diffusion cells. The diffusion cells were
filled with 5ml buffer. The buffer was stirred all the time, and the temperature was kept at 37 °C.
1ml of the buffer was checked every 30 minutes with the UV-Vis to determine how much protein
was released. After checking the O.D., the buffer was returned to the cell. The absorbance was
checked at 277 nm.

5. Result:
5.1 Microneedle fabrication:
Three microneedles were made for every experiment containing the PspA. The biggest
challenge was to cast the microneedles without bubbles. From figure 8, bubbles were easy to
form, so blowing air was one of the solutions to remove them from the microneedles before
crosslinking.
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A

B

Figure 8a: showing three microneedles in their molds. 8b: showing a microneedle after the
experiment.

5.2 Diffusion cell experiment result:
Each microneedle was placed between two cells. One of the cells was filled with a buffer
like what is shown in figure 9.
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Figure 9: The diffusion cells when the experiment was running.

The absorbance was measured every 30 minutes. Figure 10 below gives the average of
the three runs, proving the release of PspA into the buffer. From the figure, the release was
increasing with time, and the experiment was designed to run for two hours only, and it had
terminated after 2 hours. PspA concentration after 30 min was 0.001 mg/ml, and after 2 hours,
the concentration was 0.0033 mg/ml. The starting concentration in the microneedles was 0.12
mg/ml. The release was around 3% of the PspA in the gel in 2 hours. In comparison to Swiatlo's
et al. study, the released protein is higher in this study than what Swiatlo used to vaccinate the
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mice in their study (Swiatlo, King, Nabors, Mathews, & Briles, 2003). They used 0.0005 mg/ml
of PspA protein, and the release from this study's gels is 0.0033 mg/ml.
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Figure 10: The diffusion graph demonstrates a constant release until two hours mark.

6. Conclusion:
In this study, microneedles have proven to be suitable for drug delivery. PspA had a
significant molecular weight, and it was diffused through the microneedles, which means
microneedles are one of the new modern techniques for drug delivery. This technique can be
used in the future for vaccines delivery as a cheap and safe alternative to regular needles. Also,
microneedles can be used for similar molecular weight vaccines. Also, for future work, making
layers of membranes on top of each other where the lower layer has the drug, and the top layer
act like a protector and cover can increase the drug release to the buffer in diffusion cell at the
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same time. Furthermore, using a centrifuge when making microneedles can help concentrate the
drug in the tips of the microneedle and accelerate the release.
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